Life Science Company News

Reset
Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Verana Health Announces Launch of Qdata® Thyroid Eye Disease

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Verana Health, Inc.

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Renovaro Inc.

Sharecare awarded three-year NCQA Accreditation for Case Management

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Sharecare, Inc.

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  HeartSciences Inc.

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Capricor Therapeutics, Inc.

Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers

Read more ››
By: GlobeNewswire - 24 Apr 2024

Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Spectral AI, Inc.

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  CG Oncology, Inc.

ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  ALX Oncology, Inc.

Immunocore announces upcoming presentation and posters at ASCO 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Immunocore Limited

ImPact Biotech to Present Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at Upcoming Medical Conferences

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Impact Biotech, LLC

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Cue Biopharma, Inc.

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Coherus BioSciences, Inc.

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Werewolf Therapeutics, Inc.

Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Medicenna Therapeutics Corp.

Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Regeneron Pharmaceuticals Inc.

Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Cullinan Therapeutics, Inc.

Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Ultimovacs ASA

Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers

Read more ››
By: GlobeNewswire - 24 Apr 2024

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeti

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  BioXcel Therapeutics, Inc.
Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »